Capstone Investment Advisors’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
19,611
+6,501
+50% +$429K ﹤0.01% 848
2026
Q1
$904K Buy
+13,110
New +$1.02M ﹤0.01% 897
2025
Q4
– Sell
-7,925
Closed -$660K – 1893
2025
Q3
$660K Buy
7,925
+4,996
+171% +$435K ﹤0.01% 1215
2025
Q2
$274K Buy
+2,929
New +$278K ﹤0.01% 1431
2024
Q3
– Sell
-8,634
Closed -$742K – 2095
2024
Q2
$742K Buy
+8,634
New +$679K ﹤0.01% 1112
2024
Q1
– Sell
-45,081
Closed -$3.42M – 2465
2023
Q4
$3.42M Buy
+45,081
New +$3.15M 0.01% 646
2017
Q2
– Sell
-12,499
Closed -$361K – 821
2017
Q1
$361K Buy
+12,499
New +$350K 0.01% 664
2016
Q3
– Sell
-19,028
Closed -$377K – 855
2016
Q2
$377K Buy
19,028
+4,149
+28% +$79.8K 0.01% 527
2016
Q1
$275K Buy
+14,879
New +$258K 0.01% 539

Other funds holding MMSI

Capstone Investment Advisors's MMSI Position: Q2 2026 in Review

Capstone Investment Advisors increased its Merit Medical Systems (MMSI) stake by 50% in Q2 2026, buying an estimated $429K and bringing the position to 19,611 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #848.

Capstone Investment Advisors first reported a position in MMSI in Q1 2016 and has held it in 9 quarters since. The position peaked at $3.42M in Q4 2023. 405 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Capstone Investment Advisors held 19,611 shares of Merit Medical Systems worth $1.36M as of Q2 2026.
  • Capstone Investment Advisors bought 6,501 Merit Medical Systems shares in Q2 2026, an estimated $429K.
  • Merit Medical Systems made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #848 holding.
  • Capstone Investment Advisors first reported a position in Merit Medical Systems in Q1 2016 and has held it in 9 quarters since.
  • Capstone Investment Advisors's Merit Medical Systems position peaked at $3.42M in Q4 2023.
  • 405 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.